ULTRAtab Laboratories, Inc. is recalling 326,858,877 tablets across various over-the-counter brands and product categories, including pain relievers like Legatrin (acetaminophen), cold medicines, and specialty treatments like Cystex (sodium salicylate/methenamine). The recall was issued because the products were manufactured under conditions that did not meet current good manufacturing practice (CGMP) standards, which may impact the safety, quality, or consistency of the drugs. No injuries or adverse health events have been reported to date.
Manufacturing violations mean these medications may not meet federal standards for quality, identity, or purity, which could result in incorrect doses or unknown contaminants. Using medications that fail to meet these standards poses a potential health risk, although no specific incidents have been reported.
You have 2 options:
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.